Amylyx Pharmaceuticals (AMLX) Assets (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Assets of $293.6 million for Q1 2026, up 33.65% year-over-year from $219.7 million in Q1 2025, and down 11.74% quarter-over-quarter from $332.6 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Assets (2021 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Assets history runs 6 years deep, the most recent figure standing at $293.6 million for Q1 2026.
- In Q1 2026, Assets rose 33.65% year-over-year to $293.6 million; the TTM figure through Mar 2026 stood at $293.6 million (up 33.65% YoY), while the FY2025 annual figure was $332.6 million, up 71.79% from the prior year.
- Assets for Q1 2026 stood at $293.6 million, down from $332.6 million in the prior quarter.
- The five-year high for Assets was $517.5 million in Q4 2023, with the low at $181.4 million in Q3 2022.
- The 5-year median for Assets is $332.2 million (2024), against an average of $324.4 million.
- The sharpest annual moves came in 2022 and 2024: Assets surged 270.64% in 2022, then tumbled 62.58% in 2024.
- Amylyx Pharmaceuticals' Assets stood at $391.5 million in 2022, then soared by 32.19% to $517.5 million in 2023, then sank by 62.58% to $193.6 million in 2024, then surged by 71.79% to $332.6 million in 2025, then declined by 11.74% to $293.6 million in 2026.
- Business Quant data shows AMLX's Assets at $293.6 million in Q1 2026, $332.6 million in Q4 2025, and $362.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 6.18 Bn |
| 10 | Amylyx Pharmaceuticals | 4.36 Bn | 4.36 Bn | - | 264.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 264.56 Mn |
| Mar 31, 2026 | 293.60 Mn |
| Dec 31, 2025 | 332.65 Mn |
| Sep 30, 2025 | 362.74 Mn |
| Jun 30, 2025 | 194.60 Mn |
| Mar 31, 2025 | 219.68 Mn |
| Dec 31, 2024 | 193.63 Mn |
| Sep 30, 2024 | 250.71 Mn |
| Jun 30, 2024 | 332.16 Mn |
| Mar 31, 2024 | 417.46 Mn |
| Dec 31, 2023 | 517.45 Mn |
| Sep 30, 2023 | 466.58 Mn |
| Jun 30, 2023 | 453.59 Mn |
| Mar 31, 2023 | 407.96 Mn |
| Dec 31, 2022 | 391.45 Mn |
| Sep 30, 2022 | 181.44 Mn |
| Jun 30, 2022 | 225.24 Mn |
| Mar 31, 2022 | 274.44 Mn |
| Dec 31, 2021 | 105.61 Mn |